PCN310 REAL WORLD SURVIVAL OUTCOMES WITH MODIFIED DOSE SCHEDULE OF BORTEZOMIB, MELPHALAN AND PREDNISONE IN PREVIOUSLY UNTREATED TRANSPLANT INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA: A POPULATION BASED OBSERVATIONAL STUDY

May 1, 2019, 00:00
10.1016/j.jval.2019.04.428
https://www.valueinhealthjournal.com/article/S1098-3015(19)30620-5/fulltext
Title : PCN310 REAL WORLD SURVIVAL OUTCOMES WITH MODIFIED DOSE SCHEDULE OF BORTEZOMIB, MELPHALAN AND PREDNISONE IN PREVIOUSLY UNTREATED TRANSPLANT INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA: A POPULATION BASED OBSERVATIONAL STUDY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30620-5&doi=10.1016/j.jval.2019.04.428
First page :
Section Title :
Open access? : No
Section Order : 10071
Categories :
Tags :
Regions :
ViH Article Tags :